Published on
Apr 25, 2025
GLP-1 RAs in Eating Disorders: Promising or Perilous?
Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) continue to skyrocket in popularity as both approved and off-label treatments for weight loss. However, their widespread use raises significant concerns about their potential impact on people with …
Source:
Medscape
-
Neutral
